Losartan
Product Images NDC 50090-2908

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan (NDC 50090-2908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902908)

Losartan Potassium 50 mg film-coated tablets packaging label from A-S Medication Solutions. The label includes storage instructions to store at 77 degrees Fahrenheit and protect from light, specifies a package count of 90 tablets, and lists the manufacturer as Virman Life Sciences PR with distribution details in Suffolk, MA.*

FDA Label Image

Chemical Structure (Losartan 01)

Chemical structure diagram of the active ingredient Losartan potassium, showing its molecular arrangement with labeled atoms and bonds.*

FDA Label Image

Figure 1 (Losartan 02)

A line chart comparing the percentage of patients with a primary endpoint over a 66-month study period for Losartan potassium and Atenolol. The chart shows adjusted risk reduction of 13% with a p-value of 0.021, indicating statistical analysis of treatment effects over time.*

FDA Label Image

Figure 2 (Losartan 03)

A line chart comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period for Atenolol and Losartan potassium. The graph shows Atenolol with higher stroke rates than Losartan potassium, with an indicated adjusted risk reduction of 25% (p=0.001).*

FDA Label Image

Figure 3 (Losartan 04)

A forest plot chart comparing event rates and hazard ratios for Losartan potassium versus Atenolol in various patient subgroups. It includes data for primary composite outcomes and fatal/non-fatal stroke events, segmented by age, gender, race, ISH, diabetes, and history of cardiovascular disease. Hazard ratios with 95% confidence intervals are displayed graphically to show which treatment is favored.*

FDA Label Image

Figure 4 (Losartan 05)

A line graph comparing the percentage of patients with events over 48 months between two groups: one treated with Losartan potassium and the other with placebo. The graph includes a risk reduction value of 16.1% and a p-value of 0.022, indicating a statistical measure related to the treatment effect.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.